Life Science News

RSS

Mucoactive drugs block SARS-CoV-2 infection

Researchers evaluate the effects of mucociliary active molecules on SARS-CoV-2 infection in vitro.

7 Feb 2023

Study finds high levels of hydrogen peroxide in pancreatic cancer cells

Reactive oxygen species (ROS) are reputed for their involvement in carcinogenesis. Results from a study published in the journal Angewandte Chemie have now shown that the level of one such ROS,

7 Feb 2023

USC researchers identify two promising avenues for developing new ALS treatments

Each year in the U.S., 5,000 patients receive a diagnosis of ALS, an incurable neurodegenerative disease that will likely kill them within two to five years.

7 Feb 2023

Lymphatic vessels may be a previously unrecognized source of blood cells

Scientists investigating the causes of lymphoedema have made a major discovery, revealing that lymphatic vessels can produce red and white blood cells.

7 Feb 2023

Study finds a shift in information states within the brain when performing skilled tasks

The human brain prepares skilled movements such as playing the piano, competing in athletics, or dancing by 'zipping and unzipping' information about the timing and order of movements ahead of the action being performed, a new study reveals.

7 Feb 2023

Novel method for comparing whole protein-coding genes between metagenomic data detects an environmental gradient for the microbiota

Researchers from Japan compared phylogenetic trees based on proteomic data of microbiota with dendrograms of environmental factors to determine the role of environmental gradients in establishing microbial communities.

7 Feb 2023

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients. However, treatment initiation can be delayed by the variable and lengthy turnaround times involved in testing for these alterations.

7 Feb 2023

Newly identified gene signature helps assess cancer risk and optimize treatment

In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Program, and team have identified a gene signature that accurately predicts the functioning of P53 variants, important information to assessing cancer risk and optimizing choices for cancer therapeutics.

7 Feb 2023

INTEGRA introduces new 8 row and 12 column automation friendly reagent reservoirs

INTEGRA Biosciences has expanded its range of products to include 8 row and 12 column automation friendly reagent reservoirs, offering a greater variety of reservoir dimensions to suit the increasing diverse applications of automated workstations.

From INTEGRA Biosciences 7 Feb 2023

High-fat diet allows the immune system to eliminate a parasitic worm from the intestine

Scientists have discovered that a high-fat diet allows the immune system to eliminate a parasitic worm which is a major cause of death and illness in the developing world.

7 Feb 2023

Cancer-causing viruses use a human protein to evade the innate immune response

The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers.

6 Feb 2023

Study reveals mechanism of a previously unexplained type of cell death

A study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Cell Biology, details a previously unexplained type of cell death called disulfidptosis that could open the door for novel cancer therapeutic strategies.

6 Feb 2023

Researchers identify a new genetic risk factor for age-related macular degeneration

Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss of eyesight at an advanced age.

6 Feb 2023

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

The Access to Advanced Health Institute announced today that it has been awarded a project agreement worth up to $9.9 million through the Medical CBRN Defense Consortium Other Transaction Authority to develop a prototype intranasal bivalent influenza RNA vaccine candidate based on AAHI's self-amplifying RNA (saRNA) platform that targets both pandemic A(H5N1) and A(H7N9) influenza virus pathogens.

6 Feb 2023

Life Science News

Mucoactive drugs block SARS-CoV-2 infection

Study finds high levels of hydrogen peroxide in pancreatic cancer cells

USC researchers identify two promising avenues for developing new ALS treatments

Lymphatic vessels may be a previously unrecognized source of blood cells

Study finds a shift in information states within the brain when performing skilled tasks

Novel method for comparing whole protein-coding genes between metagenomic data detects an environmental gradient for the microbiota

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

Newly identified gene signature helps assess cancer risk and optimize treatment

INTEGRA introduces new 8 row and 12 column automation friendly reagent reservoirs

High-fat diet allows the immune system to eliminate a parasitic worm from the intestine

Cancer-causing viruses use a human protein to evade the innate immune response

Study reveals mechanism of a previously unexplained type of cell death

Researchers identify a new genetic risk factor for age-related macular degeneration

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

Cryo-EM provides new insights into the structure of the centromeric region

Using genetic risk scores for predicting venous thromboembolism

New method can control the growth of a substance known to cause kidney stones in dolphins

Researchers discover how a protein deficiency can prepare the brain to minimize damage after stress

Study reveals a vulnerability of macrophages that contributes to chronic inflammatory diseases

MIT study helps shed light on why the immune system mounts a dull response to lung cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News